Sable Bio
An innovative B2B software startup changing how biotech and pharma companies evaluate drug target safety for effective decision-making
London, UKsablebio.com ↗
Total raised
€4.9M
€4,900,000
Funding rounds
2
Investors
4
distinct backers
Active since
2024-02
latest 2026-02
Funding by year
EUR raised per year · 2026 YTDSignals
High confidenceRaise-next likelihood34
base rate 44% for Seed
- ▼ Raised very recently
- ▲ Up-round momentum
Exit likelihood9
base rate 12% (2+ rounds)
- ▼ Young (<3y)
Timing: too soon vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2026-02-11 | Seed | €3.2M | Episode 1 Ventures,MMC Ventures,Seedcamp | View deal → |
| 2024-02-06 | Pre-Seed | €1.7M | Episode1 Ventures,Seedcamp | View deal → |